These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12167145)

  • 1. Hemicrania continua responds to cyclooxygenase-2 inhibitors.
    Peres MF; Silberstein SD
    Headache; 2002 Jun; 42(6):530-1. PubMed ID: 12167145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rofecoxib vs celecoxib vs acetaminophen for treatment of osteoarthritis.
    Henderson P
    JAMA; 2002 Apr; 287(14):1799; author reply 1799-800. PubMed ID: 11939848
    [No Abstract]   [Full Text] [Related]  

  • 3. Rofecoxib vs celecoxib vs acetaminophen for treatment of osteoarthritis.
    Bierma-Zeinstra SM; Bohnen AM; Berger MY; Thomas S
    JAMA; 2002 Apr; 287(14):1799; author reply 1799-800. PubMed ID: 11939847
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
    Geba GP; Weaver AL; Polis AB; Dixon ME; Schnitzer TJ;
    JAMA; 2002 Jan; 287(1):64-71. PubMed ID: 11754710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence.
    Rahme E; Barkun AN; Toubouti Y; Bardou M
    Gastroenterology; 2003 Aug; 125(2):404-12. PubMed ID: 12891542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners.
    Nelson MR
    Med J Aust; 2004 Feb; 180(3):140. PubMed ID: 14748681
    [No Abstract]   [Full Text] [Related]  

  • 7. Rofecoxib for the treatment of chronic paroxysmal hemicrania.
    Lisotto C; Maggioni F; Mainardi F; Zanchin G
    Cephalalgia; 2003 May; 23(4):318-20. PubMed ID: 12716352
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners.
    Florin TH
    Med J Aust; 2004 Mar; 180(6):310-2; author reply 311-2. PubMed ID: 15012575
    [No Abstract]   [Full Text] [Related]  

  • 10. Are Cox-2 drugs the second line option in indomethacin responsive headaches?
    Porta-Etessam J; Cuadrado M; Rodríguez-Gómez O; García-Ptacek S; Valencia C
    J Headache Pain; 2010 Oct; 11(5):405-7. PubMed ID: 20517705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2-specific inhibitors: prescribing patterns in a large managed care health system and strategies to minimize costs.
    Weideman RA; Kelly KC; Kelley CL; Cryer B
    Am J Manag Care; 2002 Oct; 8(10):869-77. PubMed ID: 12395955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
    J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
    Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
    Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
    Gibofsky A; Williams GW; McKenna F; Fort JG
    Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery.
    Reuben SS; Connelly NR
    Anesth Analg; 2000 Nov; 91(5):1221-5. PubMed ID: 11049912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
    Whelton A; White WB; Bello AE; Puma JA; Fort JG;
    Am J Cardiol; 2002 Nov; 90(9):959-63. PubMed ID: 12398962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain.
    Collantes-Estevez E; Fernandez-Perez C
    Curr Med Res Opin; 2003; 19(5):402-10. PubMed ID: 13678477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice.
    Moore PA; Hersh EV
    J Am Dent Assoc; 2001 Apr; 132(4):451-6. PubMed ID: 11315375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure in Native Americans switched from celecoxib to rofecoxib.
    Fredy J; Diggins DA; Morrill GB
    Ann Pharmacother; 2005 May; 39(5):797-802. PubMed ID: 15797981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemicrania continua responsive to rofecoxib.
    Peres MF; Zukerman E
    Cephalalgia; 2000 Mar; 20(2):130-1. PubMed ID: 10961770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.